Conny Bogentoft, who holds a PhD in Medicinal Chemistry and who was an Associate Professor in Pharmaceutical Chemistry, has over 40 years of experience in the pharmaceutical industry with different companies and positions. He is the founder of Karolinska Development AB and served as its CEO between 2003 and 2011, building a portfolio of some 40 start-up companies and holding several board positions. Conny is the author of many scientific papers and patents. He was advisor to the Swedish Medical Product Agency between 2000 and 2006, and Chairman of the Swedish Pharmaceutical Society between 1994 and 2002. He was also the Vice Chairman of the Board of Lu Bio AB, a holding company partially owned by Lund University.